About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Sox9
SRY (sex determining region Y)-box 9
MGI:98371
95 phenotypes from multigenic genotypes
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
Adam17tm1.2Bbl/Adam17tm1.2Bbl
Il17atm1Yiw/Il17atm1Yiw
Sox9tm3(cre)Crm/Sox9+
involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * SJL 		dermatitis J:229771
Adam17tm1.2Bbl/Adam17tm1.2Bbl
Il23atm1Dnax/Il23atm1Dnax
Sox9tm3(cre)Crm/Sox9+
involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * SJL 		dermatitis J:229771
Adam17tm1.2Bbl/Adam17tm1.2Bbl
Sox9tm3(cre)Crm/Sox9+
B6.129(SJL)-Sox9tm3(cre)Crm Adam17tm1.2Bbl 		abnormal circulating chemokine level J:229771
abnormal epidermal layer morphology J:229771
abnormal skin morphology J:229771
dermatitis J:229771
dry skin J:229771
impaired skin barrier function J:229771
increased IgE level J:229771
increased pruritus J:229771
increased T-helper 1 cell number J:229771
increased T-helper 2 cell number J:229771
increased T-helper 17 cell number J:229771
Adam17tm1.2Bbl/Adam17tm1.2Bbl
Sox9tm3(cre)Crm/Sox9+
involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 		abnormal bone marrow cavity morphology J:144795
abnormal bone remodeling J:144795
abnormal hair growth J:144795
abnormal long bone epiphyseal plate proliferative zone J:144795
abnormal long bone hypertrophic chondrocyte zone J:144795
abnormal skin condition J:144795
abnormal spleen morphology J:144795
decreased B cell number J:144795
decreased body weight J:144795
decreased bone mass J:144795
decreased compact bone thickness J:144795
decreased hematocrit J:144795
decreased length of long bones J:144795
decreased lymphocyte cell number J:144795
decreased T cell number J:144795
decreased trabecular bone thickness J:144795
early eyelid opening J:144795
enlarged spleen J:144795
extramedullary hematopoiesis J:144795
female infertility J:144795
increased bone marrow cell number J:144795
increased circulating interleukin-17 level J:144795
increased hemoglobin content J:144795
increased interleukin-17 secretion J:144795
increased leukocyte cell number J:144795
increased macrophage cell number J:144795
increased neutrophil cell number J:144795
increased spleen red pulp amount J:144795
osteoporosis J:144795
postnatal growth retardation J:144795
premature death J:144795
reduced male fertility J:144795
short femur J:144795
thrombocytosis J:144795
Axin2tm1Wbm/Axin2+
Tg(Wt1-Sox9)92Asc/?
involves: 129 * C57BL/6 		abnormal sex gland morphology J:133933
Col2a1tm1(SOX9)Crm/Col2a1+
Sox9tm1Crm/Sox9+
involves: 129S4/SvJae 		abnormal skeleton development J:90567
decreased body size J:90567
neonatal lethality, incomplete penetrance J:90567
Ctnnb1tm1.1Smoc/Ctnnb1tm1.1Smoc
Sox9em1(cre/ERT2)Tchn/Sox9+
involves: C57BL/6 		increased incidence of tumors by chemical induction J:322311
Egfrtm1Dwt/Egfrtm1Dwt
Sox9tm3(cre)Crm/Sox9+
involves: 129S6/SvEvTac * 129S7/SvEvBrd 		abnormal epidermal layer morphology J:229771
abnormal skin morphology J:229771
dermatitis J:229771
impaired skin barrier function J:229771
increased IgE level J:229771
increased T-helper 1 cell number J:229771
increased T-helper 2 cell number J:229771
increased T-helper 17 cell number J:229771
Gnai2tm2.1Lbi/Gnai2+
Gnai3tm1Lbi/Gnai3tm1Lbi
Sox9tm3(cre)Crm/Sox9+
involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 		rib fusion J:193170
Gnai2tm2.1Lbi/Gnai2tm2.1Lbi
Gnai3tm1Lbi/Gnai3tm1Lbi
Sox9tm3(cre)Crm/Sox9+
involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 		lumbar vertebral fusion J:193170
rib fusion J:193170
Gt(ROSA)26Sortm1(CAG-Lmx1b,ALPP)Rjo/Gt(ROSA)26Sor+
Sox9tm3(cre)Crm/Sox9+
involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 		abnormal ankle joint morphology J:158676
abnormal foot pad morphology J:158676
abnormal skeleton morphology J:158676
abnormal tendon morphology J:158676
decreased skeletal muscle mass J:158676
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Sox9tm3(cre)Crm/Sox9+
Tg(tetO-Vegfa)1Kesh/0
involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ 		abnormal blood vessel morphology J:147285
increased vascular endothelial cell number J:147285
Gt(ROSA)26Sortm6Dym/?
Smotm2Amc/Smotm2Amc
Sox9tm3(cre)Crm/Sox9+
involves: 129S7/SvEvBrd * 129X1/SvJ 		abnormal temporomandibular joint morphology J:153743
small mandibular condyloid process J:153743
Hoxa13Hd/Hoxa13+
Tg(Prrx1-Sox9,-lacZ)1Haak/0
involves: C57BL/6 * DBA/2 * MYA/Hu 		abnormal hallux morphology J:121946
abnormal phalanx morphology J:121946
polydactyly J:121946
Lmx1btm1Rjo/Lmx1btm1Zfc
Sox9tm3(cre)Crm/Sox9+
involves: 129S7/SvEvBrd 		abnormal metacarpal bone morphology J:158676
normal skeleton phenotype J:158676
Shhtm1Chg/Shhtm1Chg
Tg(Prrx1-Sox9,-lacZ)1Haak/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2 		abnormal limb bud morphology J:121946
Sox8tm1Weg/Sox8+
Sox9tm2Crm/Sox9tm2Crm
Tg(Nr5a1-cre)5Asc/?
involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * CBA 		abnormal primary sex determination J:89368
absent Leydig cells J:89368
cryptorchism J:89368
decreased Sertoli cell number J:89368
sex reversal J:89368
Sox8tm1Weg/Sox8tm1Weg
Sox9tm2.1Crm/Sox9+
involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * C57BL/6J 		abnormal primary sex determination J:89368
abnormal seminiferous tubule morphology J:89368
sex reversal J:89368
Sox8tm1Weg/Sox8tm1Weg
Sox9tm2Crm/Sox9tm2Crm
Tg(Nr5a1-cre)5Asc/?
involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * CBA 		abnormal primary sex determination J:89368
absent Leydig cells J:89368
cryptorchism J:89368
decreased Sertoli cell number J:89368
sex reversal J:89368
Sox9em1(cre/ERT2)Smoc/Sox9+
Tnfsf18em1Pwan/Tnfsf18em1Pwan
involves: C57BL/6J 		abnormal response to injury J:346395
abnormal T cell activation J:346395
decreased CD8-positive, alpha-beta T cell number J:346395
decreased circulating alanine transaminase level J:346395
decreased circulating aspartate transaminase level J:346395
decreased hepatoblast number J:346395
decreased inflammatory response J:346395
Sox9em1(cre/ERT2)Tchn/Sox9+
Stk26tm2.1Zzh/Stk26tm2.1Zzh
involves: 129P2/OlaHsd * C57BL/6 		abnormal enterocyte proliferation J:322311
decreased incidence of tumors by chemical induction J:322311
Sox9em1(cre/ERT2)Tchn/Sox9+
Stk26tm2.1Zzh/Stk26tm2.1Zzh
involves: C57BL/6 * SJL 		increased incidence of tumors by chemical induction J:322311
Sox9tm2Crm/Sox9+
Rr80em1Jwsk/Rr80+
E2f1Tg(Wnt1-cre)2Sor/E2f1+
involves: 129S7/SvEvBrd * C3H * C57BL/6J * FVB/NJ 		abnormal mandible morphology J:306395
mandibular condyloid process hypoplasia J:306395
postnatal growth retardation J:306395
short mandible J:306395
Sox9tm3(cre)Crm/Sox9+
Sp7tm1Crm/Sp7tm2Crm
involves: 129S7/SvEvBrd * C57BL/6 * SJL 		abnormal axial skeleton morphology J:102495
abnormal bone mineralization J:102495
abnormal bone ossification J:102495
abnormal limb bone morphology J:102495
abnormal osteoblast differentiation J:102495
abnormal rib morphology J:102495
abnormal skeleton development J:102495
abnormal trabecular bone morphology J:102495
abnormal vertebrae morphology J:102495
neonatal lethality, complete penetrance J:102495
Sox10tm1Ngan/Sox10+
Sox9tm2Crm/Sox9+
Tg(Rr141-cre)1Ksec/0
involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 * CBA 		dilated cochlea J:332093
Sox10tm1Ngan/Sox10+
Sox9tm1.1Ksec/Sox9+
Tg(Rr141-cre)1Ksec/0
involves: 129S/SvEv * C57BL/6 * CBA 		dilated cochlea J:332093
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/12/2024
MGI 6.24 		The Jackson Laboratory